ArticleCureus2025
Clinicopathological Features and Therapeutic Outcomes of Head and Neck Sarcomas: A 14-Year Retrospective Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Head and neck sarcomas are rare malignant tumors with a wide histological diversity. Their diagnosis and management remain challenging because of their complex anatomical location and aggressive behavior. The objective of this study was to analyze the epidemiological, clinical, and paraclinical characteristics of head and neck sarcomas over 14 years in a tertiary military hospital, with a focus on survival, recurrence, and treatment response. A retrospective descriptive study was conducted in the ENT Surgery Department of the Military Hospital of Tunis from January 2010 to December 2023. Nineteen patients diagnosed with head and neck sarcomas were included. Data regarding demographics, clinical presentation, imaging, histology, treatment, and outcomes were analyzed. All patients underwent radiological evaluation to determine locoregional and distant tumor extension. Histological diagnosis was obtained by biopsy in 10 cases and from surgical specimens in nine. The study included 10 males and nine females, aged two to 76 years (mean age = 43 years). The most frequent histological subtypes were synovial sarcoma and embryonal rhabdomyosarcoma. Surgery was the main treatment in nine patients, often combined with adjuvant radiotherapy or chemotherapy. Reconstructive surgery using a frontal flap was performed in one case of nasal angiosarcoma. Two patients were treated with concomitant radio-chemotherapy, four received exclusive radiotherapy, and one patient received only chemotherapy. Distant metastases were identified in two cases. The mean follow-up was 24 months (range: two months to five years). Local recurrence occurred in two patients, and four patients experienced disease-related mortality. Head and neck sarcomas require complex and multidisciplinary management. Surgery remains the cornerstone of treatment when feasible, but therapeutic strategies must be individualized based on tumor location, histological type, and extension. Optimizing outcomes depends on early diagnosis and tailored, case-specific multimodal approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.